Sofinnova Investments, Inc. Esperion Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $1.35 Million - $2.16 Million	-36,599 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$40.74 - $51.41 $4.67 Million - $5.89 Million	-114,562 Reduced 75.79%	36,599 $1.62 Million
Q2 2018 Nov 15, 2018	BUY	$36.2 - $76.4 $4.91 Million - $10.4 Million	135,590 Added 870.79%	151,161 $5.92 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $563,670 - $1.19 Million	15,571 New	15,571 $610,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.